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Role of plasma arginine vasopressin in the impaired water diure-
sis of isolated glucocorticoid deficiency in the rat. The role of ant i-
diuretic hormone in the impaired water excretion of isolated
glucocorticoid deficiency was investigated in the thyroxin-re-
placed, anterior hypophysectomized rat. Hypophysectomized
rats demonstrated marked impairment in the excretion of an oral
water load (32 4% vs. 94 4%), plasma hypoosmolality (281
2 vs. 289 2 mOsmlkg), and hyponatremia (129 I vs. 140 I
mEq/liter) compared to controls (all P < 0.001). These defects
were associated with increased levels of plasma arginine vaso-
pressin (3.05 0.45 vs. 1.38 0.11 pg/mI; P <0.001). Following
physiologic corticosterone replacement in hypophysectomized
rats, the percentage of the water load excreted, free water clear-
ance, plasma sodium, plasma osmolality, and circulating levels
of plasma arginine vasopressin were all restored to control val-
ues. This correction of water diuresis occurred in the absence of
changes in GFR or solute excretion. The defect in water excre-
tion and the elevation of plasma arginine vasopressin could not
be corrected by chronic extracellular volume expansion in the
absence of glucocorticoid replacement. It is concluded that (a)
increased secretion of vasopressin plays an important role in the
impaired water diuresis of isolated glucorticoid deficiency; (b)
physiologic corticosterone replacement corrects both the im-
paired water excretion and the increased secretion of vasopres-
sin associated with glucocorticoid deficiency; and (c) a volume-
independent nonosmotic stimulus to vasopressin secretion may
be activated by the chronic absence of glucocorticoid hormones.
Role de l'arginine vasopressine du plasma dans l'incapacité de
diluer l'urlne au cours du deficit isolé en glucocorticoIdes chez le
rat. Le role de l'hormone antidiurétique dans l'incapacité a di-
luer l'urine au cours du deficit isolé en glucocorticoldes a été
étudié chez des rats ayant subi une hypophysectomie antérieure
et compensés par de Ia thyroxine. Les rats hypohysectomisés
ont un deficit important de l'excrCtion d'une charge en eau (32
4% contre 94 4%), une hypoosmolalite plasmatique (281 2
contre 289 2 mosmlkg). et une hyponatrémie (129 I contre
140 I mEq/liter), par comparaison aux contrOles (P <0,001).
Ces modifications sont associées a des concentrations plasma-
tiques élevCes d'arginine vasopressine (3,05 0,45 contre 1,38
0,11 pg/mI; P < 0,001). L'administration de corticostérone aux
rats hypophysectomisés ramène aux valeurs contrOles Ic pour-
centage de Ia charge d'eau excrétée, Ia clearance de l'eau fibre,
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Ia natrémie, l'osmolalité plasmatique et Ia concentration circu-
lante d'arginine vasopressine. Cette restauration de Ia diurèse
aqueuse est observée en l'absence de modifications du debit de
filtration glomérulaire ou du debit urinaire de substances dis-
soutes. Le deficit d'excrétion de l'eau et l'augmentation de
l'arginine vasopressine du plasma ne peuvent pas être corrigés
par une expansion chronique du volume extra-cellulaire en
l'absence de traitement substitutif par les glucocorticoIdes. U est
conclu que: (a) l'augmentation de Ia sécrétion de vasopressine
joue un rOle important dans l'incapacité de diluer les urines oh-
servée au coors du deficit en glucocorticoldes; (b) un traitement
substitutif par des doses physiologiques de corticostérone cor-
rige a Ia fois Ic deficit d'excrétion de l'eau et Ia sCcrétion exces-
sive de vasopressine associés au deficit en glucocorticoldes; et
(c) un stimulus, non osmotique et indépendant du volume extra-
cellulaire, de Ia sécrétion de vasopressine peut Ctre active par
l'absence chronique d'hormones glucocorticoIdes.
Impaired excretion of water by the kidney is a
long-recognized characteristic of primary and sec-
ondary adrenal insufficiency [1-6]. Although this
phenomenon has been investigated extensively [5-
17], the precise pathophysiology of this defect has
not been defined. Major controversy concerning the
primary causal factor has focused on the possible
role of increased secretion of antidiuretic hormone
(ADH) versus a direct effect on water permeability
of the distal nephron.
The recent observation that ethanol administra-
tion restores water excretion to normal in patients
with anterior hypopituitarism and glucocorticoid
deficiency has provided indirect evidence of in-
creased secretion of ADH [5, 6]. Measurements of
plasma vasopressin by bioassay in patients and ani-
mals with adrenal insufficiency have yielded, how-
ever, directly conflicting results [7, 8, 10]. Alterna-
tively, it has been postulated that glucocorticoid
deficiency impairs the renal excretion of water by
directly increasing the permeability to water of dis-
tal nephron segments [7, 11-13]. The demonstration
of a defect in water excretion in adrenalectomized
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rats with congenital absence of ADH (Brattleboro
strain) has been interpreted as indirect evidence in
favor of this hypothesis [15].
Previous studies of primary adrenal insufficiency
in man and adrenalectomized animals have been
limited by problems inherent in the study of com-
bined mineralocorticoid and glucocorticoid defi-
ciency [7—10, 13—15]. In some of these earlier stud-
ies [9—11, 13, 15, 17], the use of pharmacologic re-
placement doses of glucocorticoids, which possess
significant mineralocorticoid activity, and the fail-
ure to replace mineralocorticoids [8, 10, 14] have fur-
ther confused identification of the separate effects
of the two classes of adrenal steroids on renal water
handling. In a more recent study, Boykin et al have
shown that following withdrawal of glucocorticoids,
adrenalectomized dogs replaced with mineral-
ocorticoids have a marked impairment of water ex-
cretion that correlates closely with increased circu-
lating levels of plasma arginine vasopressin [18].
The observed tachycardia and reduced stroke vol-
ume, which may have initiated a baroreceptor-me-
diated release of vasopressin in these animals, was
attributed to glucocorticoid deficiency. In this mod-
el, the possibility must be considered that combined
epinephrine-glucocorticoid deficiency contributed
to the observed alteration in hemodynamics be-
cause removal of the adrenal medulla decreases cir-
culating levels of plasma epinephrine [19, 20].
In the present study, we have used the thyrox-
in-replaced anterior hypophysectomized rat to pro-
vide another model of glucocorticoid deficiency.
Because anterior hypophysectomy also results in
the loss of other pituitary hormones, whose effects
on water metabolism are unknown, we examined
the ability of physiologic doses of corticosterone
(which is the naturally occurring glucocorticoid in
the rat) to reverse specifically the defect in water
metabolism. Because pituitary insufficiency is the
most common cause of glucocorticoid deficiency in
man [21], the present model would be expected to
parallel more closely the abnormalities in water me-
tabolism most commonly encountered in clinical
medicine.
Methods
Male Sprague-Dawley rats, each weighing 170 to
190 g, were obtained from Charles River Breeding
Laboratories (Wilmington, Massachusetts) 6 days
following anterior hypophysectomy with a retro-
esophageal surgical approach. This method permits
removal of the anterior hypophysis without damage
to the posterior lobe [22]. Unoperated litter-mates
served as controls. All rats were kept in individual
metabolic cages and were allowed free access to a
standard laboratory diet (Purina Rat Chow, Ralston
Purina Co., St. Louis, Missouri) and tap water. Be-
ginning 7 days following surgery, we replaced all
hypophysectomized rats daily with thyroxin (2 Lg/
100 g body wt, i.p.; L-thyroxin, Sigma Chemical
Co., St. Louis, Missouri). Body weight was record-
ed in all animals every 7 days.
Determining baseline renal water excretion fol-
lowing anterior hypophysectomy. On day 14, a
baseline measurement of water excretion was deter-
mined in 32 thyroxin-replaced hypophysectomized
rats. In this and subsequent studies, an oral water
load (5% body weight of a 1% dextrose-in-water so-
lution) was administered at 8 A.M. to conscious rats
by gastric intubation. Urine was collected under oil,
and urine flow and osmolality were measured at
hourly intervals from 1 hour before until 3 hours af-
ter the water load. Water excretion was expressed
as the percent of the water load excreted within 3
hours. Five normal rats were similarly studied at
the same time to control for normal variation in wa-
ter excretion. Hypophysectomized rats excreted 34
3% of the water load in 3 hours compared to 101
4% in controls (P <0.001).
Effects of glucocorticoid deficiency and physio-
logic corticosterone replacement on renal i'ater ex-
cretion, plas,na A VP, and plas,na corticosterone in
hypophysecto,nized rats (groups I to 4). Following
baseline studies, all 32 hypophysectomized and 12
control rats were placed in four groups: group 1, 12
normal control rats; group 2, 18 hypophysecto-
mized rats receiving only thyroxin; group 3, 7 hy-
pophysectomized thyroxin-replaced rats receiving
300 g/100 g body wt corticosterone (Sigma Chem-
ical Co., St. Louis, Missouri) given in two divided
doses; group 4, 7 hypophysectomized thyroxin-re-
placed rats receiving 600 sg/l00 g body wt corticos-
terone given in two divided doses.
Hypophysectomized rats were allocated to each
of three groups such that mean baseline water ex-
cretion (± sEM) was similar in groups 2, 3, and 4.
The replacement doses of corticosterone, the pre-
dominant naturally occurring glucocorticoid in this
species [23], were derived from data indicating a
basal corticosterone secretory rate in the rat of 1150
to 1650 g/i00 g body wt per 24 hours [24]. Corti-
costerone was administered i.p. every 12 hours at 7
A.M. and 7 P.M. to animals in groups 3 and 4. These
dosages of corticosterone were calculated in-
tentionally to be in the low physiologic range to
minimize the possibility of excessive plasma con-
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centrations of corticosterone at the time of water
loading (60 to 240 mm following the 7 A.M. dose).
Renal water excretion following an oral water
load was measured again in all groups on day 21,
following 7 days of corticosterone replacement in
groups 3 and 4. Twenty-four hour urine collections
for the determination of creatinine clearance and
sodium excretion were obtained on day 22. On day
23, a third water load was administered. In this
study, urine was collected for 90 mm, at which time
animals were rapidly decapitated by guillotine dur-
ing water diuresis. Blood issuing from the vessels of
the trunk was collected in chilled heparinized tubes
and centrifuged at 00 C. Aliquots of plasma were an-
alyzed for sodium and creatinine concentrations
and osmolality. The remaining plasma was stored at
—20° C and subsequently assayed for corticos-
terone, thyroxin, and arginine vasopressin. After
the animals were sacrificed, both adrenal glands
were removed and weighed on an analytical balance
(Sartorius 2474, Brinkman Instruments, Inc., West-
bury, New York).
Effect of combined administration of mineral-
ocorticoids and glucocorticoids on renal water ex-
cretion, GFR, and plasma AVP in hypophysecto-
mized rats (group 5). To exclude the possibility that
partial mineralocorticoid deficiency was contrib-
uting to the defect in water excretion, we studied a
group of 7 thyroxin-replaced hypophysectomized
rats during oral water-loading on three different oc-
casions: while receiving no steroid replacement (14
days following hypophysectomy); following 7 days
of replacement with corticosterone alone (600 g/
100 g body wt); and following 7 days of combined
corticosterone and deoxycorticosterone acetate
(250 pg/day) (DOCA; Organon Inc., West Orange,
New Jersey) administration (day 28). At the termi-
nation of this period, animals were sacrificed during
water diuresis, and urine and plasma determina-
tions were performed as described for groups 1 to 4.
Effects of chronic extracellular volume expansion
on renal water excretion, plasma AVP, and GFR in
glucocorticoid deficient rats (group 6). To assess
the effect of extracellular fluid volume expansion
alone on water excretion and plasma AVP in gluco-
corticoid deficiency, we subjected a group of 7
thyroxin-replaced hypophysectomized rats (group
5) to identical oral water loading on two separate
occasions: before (day 14) and after (day 28) 2
weeks of extracellular volume expansion. Volume
expansion was accomplished by replacing drinking
water with normal saline in 2.5% dextrose in water
and by the administration of DOCA, 250 pg/day. On
day 30, rats were guillotined at 90 mm following an
oral water load. Plasma and urine samples were
processed in a manner identical to groups I to 4.
Analytical methods. Plasma and urine osmolality
was measured by freezing-point depression (Ad-
vanced Instruments, Inc., Needham Heights, Mas-
sachusetts); plasma and urine sodium concentra-
tion, by flame photometry (Instrumentation Labo-
ratory, Lexington, Massachusetts); and plasma and
urine creatinine, by an autoanalyzer (Technicon
Corp., Tarrytown, New York) with the Stevens
and Sheggs modification of the method of Folin and
Wu [25]. Total serum thyroxin was measured by a
competitive protein-binding assay in groups 1, 2,
and 4 [26]. Plasma corticosterone was measured
with a competitive binding radioassay by the
method of Murphy [27]. Plasma arginine vasopres-
sin was measured on coded samples by radioimmu-
noassay [28] with a highly specific antibody to argi-
nine vasopressin that does not crossreact with
oxytoxin. Arginine vasopressin in rat plasma is im-
munologically stable when stored for 4 to 6 weeks
under the specific conditions of this study. This as-
say can measure plasma AVP at concentrations as
low as 0.5 pg/mi in sample volumes of 1.0 ml or less.
All statistical computations were performed on
an Olivetti desktop computer (model p602). All val-
ues represent the mean SEM. Data were com-
pared by using the paired and unpaired Student's t
test as indicated in the Results section.
Results
Baseline water excretion following anterior hy-
pophysectomy. Fourteen days following hypophy-
sectomy, mean baseline water excretion (percent of
water load excreted in 3 hours) was 32 3% in hy-
pophysectomized rats receiving only thyroxin re-
placement. Hypophysectomized animals were then
randomly assigned to groups 2 to 4. The mean base-
line excretion of the water load was 32 5%, 31
7%, and 32 6% in groups 2, 3, and 4, respectively.
Thyroid and adrenal function and body weight in
control and hypophysectonized rats (groups 1 to 4).
Serum thyroxin was 5.6 0.3, 6.9 0.7, and 7.7
0.7 pg/dl in groups 1, 2, and 4, respectively. Adre-
nal weight was 13.3 0.5 mg/lOO g body wt in con-
trols (group 1) and decreased to 3.8 0.1 mg in
group 2 (P < 0.001). A similar reduction in adrenal
weight was observed in rats of groups 3 to 6. Plasma
corticosterone concentration was 24.6 2.9 g/dl
in control (group 1) compared to 0.8 g/dl in
group 2 rats (P <0.001). Following I week of corti-
costerone replacement in groups 3 and 4, plasma
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corticosterone increased to 7.7 2.3 and 8.2 0.9
g/dl, respectively (both P < 0.001); both values
are within the normal range of plasma corticoste-
rone (5.35 1.71 mg/dl)at 10A.M. in the unstressed
rat [29]. Control rats (group 1) gained 6 1% body
wt per week, whereas hypophysectomized rats
(group 2) showed no gain in weight (1 1% weight
gain per week). A similar failure to gain weight was
also observed in hypophysectomized rats in groups
3 to 6.
Effects of glucocorticoid deficiency and physio-
logic corticosterone replacement on renal water ex-
cretion and renal function (groups / to 4, Table 1,
Figs. I and 2). At 21 days following hypophysec-
tomy, glucocorticoid-deficient animals (group 2) ex-
creted 32 4% of the oral water load within 3
hours, in contrast to 94 4% in control rats (P <
0.001). Minimum urine osmolality was 343 55
mOsmlkg in group 2 compared with 98 7 mOsml
kg in controls (P < 0.001) (Table 1). During water
diuresis, plasma sodium concentration and Os-
molality were reduced in group 2 animals (129 1
mEq/liter and 281 2 mOsmlkg) compared to con-
trols (140 1 mEq/liter and 289 3 mOsmlkg; both
P < 0.001). Creatinine clearance (Table 1) de-
creased following hypophysectomy from 930 53
1Jmin/100 g body wt in controls to 651 33 in
group 2 (P < 0.001). Twenty-four hour sodium ex-
cretion was similar in control and group 2 rats. The
impairment in water excretion in group 2 rats was
associated with a marked reduction in free water
clearance from 20 2 .dJminJ 100 g body wt in con-
trols to —3 2 (P < 0.00 1). Similar changes in frac-
tional free water clearance were observed. Osmolal
clearance decreased from 22 2 dImin/100 g body
wt in controls to 13 I dImin in group 2 (P <
0.001). No reduction was observed, however, when
Table 1. Renal function and parameters of water excretion following an oral water load in control and hypophysectomized animals
(groups Ito 4)
Oral water
load
excreted in CH,() CH,WGFR Cosm C05mIGFR Minimum Ccr UNaV
P0,,, PNa 180 mm pJ/minIlOO pJ/min/ml pJ/min/100 p.1/minim! Uosm pJ/min/100 p.Eq/mini/00
Group N rnOsmikg mEqiliter % g body wt GFR g body wi' GFR mOsm/kg g body wt g body WI
20±2 23±3 22±2 23±2 98±7 930±53 0.66±0.03I (controls) 12 289 2 140 I 94 4
2 (hypox,
noCS) 18 281 2 129 1 32 4 —3 2 —4 3 13 1 20 2 343 55 651 33 0.63 0.02
3 (hypox,
300p.gCS) 7 290 2 140 1 71 8 14 3 21 4 18 2 26 3 203 26 690 58 0.74 0.06
4 (hypox,
600p.gCS) 7 294±3 140±2 87±9 16±2 33±3 15±2 34±7 162±14 516±60 0.54±0.06
Oral H20 load
5% body wt
I
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Fig. 1. Time course of excretion of an oral water load in controls
(group I, closed circles), in hypophysectomized rats receiving no
glucocorticoid replacement (group 2, open circles), and in hy-
pophysectomized rats receiving corticosterone at 300 jzg/lOO g
body wt (group 3, open triangles) and 600 p.g/l00 g body WI (group
4, closed triangles). Group 4 animals were not statistically dif-
ferent from controls at both 120 and 180 mm. See Fig. 2 for statis-
tical comparisons between groups at 180 mm. P values were ob-
tained by unpaired Student's t test.
P values between groups
I vs. 2 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 NS <0.001 <0.001 NS
3 vs. 2 <0.001 <0.001 <0.001 <0.001 <0.001 <0.05 NS <0.05 NS NS
4vs.2 <0.001 <0.001 <0.001 <0.001 <0.001 NS NS <0.01 NS NS
3 vs. 1 NS N5 <0.025 N5 N5 NS NS <0.005 <0.01 NS
4vs. I NS NS NS NS <0.05 <0.05 NS <0.005 <0.001 NS
a Data are presented as the mean SEM; P values were obtained using the unpaired Student's I test. N denotes number of rats.
Abbreviations are: hypox, hypophysectomized rats; CS. corticosterone given (per 100 g body wt); Psm, plasma osmolality; Uosm, urine
osmolality.
400 I
200 -
100
0
0*
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osmolal clearance was corrected for differences in
GFR.
Corticosterone replacement in hypophysecto-
mized rats resulted in complete correction of both
the percentage of the water load excreted and free
water clearance with restoration of plasma sodium
concentration and osmolality to control values
(Table 1, Figs. I and 2). Group 3 rats receiving low-
dose corticosterone excreted 71 8% of the water
load in 3 hours (P < 0.001 vs. group 2). Whereas
this value was statistically lower than that of control
rats (P < 0.025), water excretion was restored corn-
4.0
3.0
2.0 —
1.0 —
I I I
270 280 290 300
P0,,,, m0sm/kg H20
Fig. 3. Relationship of plasma AVP to plasma osmolality during
water diuresis (90 mm following water load) in control rats (•),
in hypophyseclo,nized rats receiving no glucocorticoid replace-
ment (Q), and in hypophysectomized rats receiving corlicosle-
rone at 300 ,xg/IOO g body ut () and 600 pg/l00 g body wt (A).
A significant elevation of plasma AVP was observed in gluco-
corticoid-defIcient rats compared to controls (P < 0.001). Plasma
AVP was not significantly different from controls in corticoste-
rone-replaced hypophysectomized rats.
pletely to control values in group 4 animals receiv-
ing the higher replacement dose of corticosterone.
In group 4 animals, the excretion of an oral water
load was identical to controls at both 120 and 180
mm following water loading (Fig. 1). This improve-
ment in urine flow was associated with an increase
in free water clearance to 14 3 and 16 2 p11mm]
100 g body wt in groups 3 and 4, respectively (Table
I). Urinary diluting ability (minimum urine os-
molality) improved significantly following corticos-
terone replacement in group 3 (203 26 mOsmlkg)
and in group 4 (162 14 mOsmlkg); these values,
however, remained slightly elevated compared to
control rats. Creatinine clearance was reduced to
690 58 and 516 60 pi'minIlOO g body wt in
groups 3 and 4, respectively, values not different
from glucocorticoid deficient rats (group 2). Urinary
sodium excretion in groups 3 and 4 was similar to
values observed in groups 1 and 2.
Plasma AVP in groups 1(04 (Fig. 3). During wa-
ter diuresis, plasma AVP was significantly elevated
to 3.05 0.45 pg/mI in group 2 compared to 1.38
0.11 pg/mI in controls (P <0.001). This elevation of
plasma AVP occurred despite a lower plasma os-
molality in group 2 animals: 281 2 vs. 289 2
mOsmlkg (P < 0.01). Corticosterone replacement
resulted in a significant decrease in plasma AVP
during water diuresis in both groups 3 (1.73 0.33
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Fig. 2. Excretion of oral water load and urinary dilution at 180
mm in controls (group l). in hypophysectomized rats receiving
no glucocorticoid replacement (group 2), and in hypophysecto-
inized rats receiving curl icoslerone at 300 p.g/IOO g body ut
(group 3) and 600 zg/l00 g body ut (group 4). Asterisks indicate
statistical comparison to group I rats (* = P < 0.05. ** = P <
0.01. = P <0.00!). Crosses indicate statistical comparison to
group2rats(+=P<0.05.++ =P<0.0I,+++P<0.00l).
P values were obtained by unpaired Student's i test.
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pg/mi; P < 0.05) and group 4 (1.34 0.24 pg/mI; P
< 0.005) compared to group 2 rats. These values
were not statistically different from controls.
Effect of coin bined administration of mineral-
ocorticoids and glucocorticoids on renal water ex-
cretion, GFR, and plasma AVP in hypophysecto-
inized rats (group 5, Table 2). The persistent mild
defect in the minimum urine osmolality observed in
glucocorticoid-replaced hypophysectomized rats
(groups 3 and 4) was not abolished by the combined
administration of mineralocorticoid and glucocorti-
coid hormones (group 5). Following corticosterone
replacement alone, water excretion increased in
this group from 19 5% to 103 6% of the oral
water load, and the minimum urine osmolality fell
from 427 88 to 157 13 mOsmlkg. It is of note,
however, that no further improvement in these pa-
rameters was observed when both DOCA and corti-
costerone were given together to this same group of
rats. Creatinine clearance was 710 31 piIminIlOO
g body wt during combined mineralocorticoid and
glucocorticoid administration, a value significantly
lower than that of control rats (group I; P <0.005).
Plasma AVP during water diuresis was 1.5 0.2 pg/
ml during combined replacement, a value not dif-
Table 2. Water excretion in hypophysectomized rats before and
during corticosterone and DOCA replacement (group 5) and
before and during chronic volume expansion (group 6)
Oral water load
excreted
in' 180 mm
%
Minimum U0,,,
mOsm/kg
GroupS (N = 7)
(a)GC deficient
(b)CS replaced(c)CS + DOCA
replaced
19 5
103 6
113 5
427 88
157 13
142 7
P values
a vs. b
bvs.c
<0.001
NS
<0.02
NS
Group6(N = 7)
(a)GCdeficient
(b)DOCA + NaCI
19 4
36 6
480 93
230 42
P values
a vs. b <0.02 <0.05
Data are presented as the mean SEM. P values were ob-
tained with the paired Student'sr test. N denotes number of rats.
Subentries under groups are defined as: glucocorticoid (GC)
deficient, hypophysectomized rats studied while receiving no
corticosterone; CS replaced, hypophysectomized rats studied
following 7 days of corticosterone (600 gI100 g body wt);
CS + DOCA, hypophysectomized rats studied following 7 days
of combined corticosterone (600 zg/l00 g body wt) and DOCA
(250 pg/day); DOCA + NaCI, hypophysectomized rats studied
following 14 days of DOCA (250 pg/day) and normal saline.
ferent from control rats (group 1) or hypophysecto-
mized rats receiving only corticosterone (groups 3
and 4).
Renal function, water excretion, and plasma
AVP before and after ext racellular fluid volume ex-
pansion in glucocorticoid-deficient rats (group 6,
Table 2). Following 14 days of extracellular volume
expansion with a high sodium chloride intake and
DOCA, 24-hour urinary sodium excretion was 4.7
0.7 Eq/minIl00 g body wt in glucocorticoid-
deficient rats, a sevenfold increase compared to
groups I to4(allP <0.001) and indicative of miner-
alocorticoid escape. The natriuresis was accom-
panied by an increase in creatinine clearance to 910
43 plImin/100 g body wt, a value not different
from controls.
Prior to volume expansion, hypophysectomized
rats again demonstrated a profound impairment of
water diuresis with excretion of 19 4% of the wa-
ter load and a minimum urine osmolality of 480 93
mOsrnlkg. Following extracellular volume expan-
sion and restoration of GFR to normal, there was a
small although significant increase in the percentage
of the water load excreted to 36 6% (P < 0M2)
and a decrease in the minimum urine osmolality to
230 42 mOsmlkg (P <0.05).
Despite chronic volume expansion and restora-
tion of GFR, during peak water diuresis plasma AVP
was 3.2 0.8 pg/mI in group 6 rats, a value similar to
that observed in the nonvolume expanded glucocor-
ticoid-deficient rats (group 2) and significantly high-
er than that in control animals (P < 0.05).
Discussion
The results demonstrate that the defect in renal
water excretion resulting from selective glucocorti-
coid deficiency in the rat is associated with an ele-
vation of immunoreactive plasma AVP. Physiologic
glucocorticoid replacement resulted in a restoration
of renal water excretion, correction of hyponatre-
mia and hypoosmolality, and suppression of plasma
AVP to control values. These findings suggest an
important role for increased secretion of ADH in
the pathogenesis of impaired water excretion in
glucocorticoid deficiency.
The role of ADH in the defect in water excretion
in glucocorticoid deficiency has been a source of
controversy since Gaunt, Birnie, and Eversole [I]
in 1949 first identified increased amounts of anti-
diuretic substance in serum of adrenalectomized
rats. In 1960, Dingman and Despointes [9] reported
that patients with Addison's disease were hypersen-
sitive to the antidiuretic action of nicotine and sug-
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gested that glucocorticoids modulate the release of
vasopressin from the neurohypophysis. More re-
cent studies have demonstrated that ethanol, a po-
tent inhibitor of ADH release, can restore renal wa-
ter excretion to normal in patients with anterior
hypopituitansm and glucocorticoid deficiency [5,
6]. This observation provided indirect evidence of
increased secretion of ADH. Attempts, however, to
quantitate plasma vasopressin directly by bioassay
yielded conflicting results. Kleeman, Czaczkes, and
Cutler [7] found undetectable levels of ADH in the
plasma of patients and animals with adrenal in-
sufficiency during water diuresis. In contrast, Ah-
med et al [10], using a different bioassay, found
markedly elevated levels of plasma AVP in patients
with primary and secondary adrenal insufficiency.
These discrepant results may be due to the lack of
sensitivity and reproducibility of the bioassay tech-
niques used [30, 31]. In the present studies, a highly
specific and sensitive radioimmunoassay for plasma
AVP was used [28]. Previous studies have con-
firmed the reproducibility of this assay under a van-
ety of conditions that inhibit or stimulate ADH re-
lease [28, 32—34]. The present data reveal a signifi-
cant increase in plasma AVP during water diuresis
in glucocorticoid-deficient rats, at a time when
plasma hypoosmolality should have inhibited AVP
secretion. Replacement of the naturally occurring
glucocorticoid in physiologic doses resulted in sup-
pression of plasma AVP to control values. These
results are in agreement with a recent report by
Boykin et al [18], who also observed increased lev-
els of plasma AVP by radioimmunoassay in adre-
nalectomized dogs replaced with physiologic doses
of mineralocorticoid.
Previous investigations of the mechanism of im-
paired water excretion in glucocorticoid-deficient
animals have used bilateral adrenalectomy [3, 7, 8,
15, 16, 18]. Limitations of this model include the
production of coexistent mineralocorticoid defi-
ciency with the requirement for exogenous replace-
ment of mineralocorticoids and the creation of a
state of epinephrine deficiency. Deficiency of mm-
eralocorticoids, by itself, with its attendant de-
crease in extracellular fluid volume, can impair wa-
ter excretion both by reducing GFR and by increas-
ing the secretion of ADH [16, 35]. The present
model using the thyroxin-replaced anterior hy-
pophysectomized rat, permitted examination of the
specific effect of glucocorticoid deficiency on renal
water excretion without concomitant epinephrine
or mineralocorticoid deficiency. Previous studies in
rats [24, 36], dogs [37], and man [38, 39] have shown
that hypophysectomy results in glucocorticoid defi-
ciency whereas aldosterone secretion remains unaf-
fected. In the present experiments, glucocorticoid
deficiency in hypophysectomized rats was docu-
mented by marked reduction in adrenal weight and
plasma corticosterone concentration. Furthermore,
corticosterone levels in glucocorticoid-replaced rats
were within the normal range of unstressed rats of
the same strain [29]. The elevation of plasma corti-
costerone above normal in group I (control) rats
can be attributed to stress-induced ACTH release
during the 4-hour water-loading procedure in ani-
mals with an intact pituitary adrenal axis. The lower
plasma corticosterone concentrations observed in
the corticosterone-replaced hypophysectomized
animals are accounted for by the inability to secrete
ACTH following anterior hypophysectomy.
The defect in water excretion in glucocorticoid-
deficient rats was characterized by an inability to
excrete an oral water load, a reduction in absolute
and fractional free water clearance, and an increase
in the minimum urine osmolality. Following 7 days
of corticosterone replacement (group 4), both the
ability to excrete a water load and the free water
clearance were restored to normal; urinary diluting
ability improved substantially, although the mini-
mum urine osmolality remained slightly higher than
that of controls. The ability of physiologic replace-
ment doses of corticosterone to restore the excre-
tion of a water load indicated that the primary cause
of the impairment in water metabolism was ACTH-
mediated glucocorticoid deficiency itself and not
the loss of some other anterior pituitary hormone.
The inability to restore the minimum urine os-
molality completely to normal may be due to the
deficiency of some other anterior pituitary hormone
or to the persistent reduction in GFR, which has
been shown to impair renal diluting capacity even in
the absence of ADH [40]. The persistent reduction
in GFR could indicate that the corticosterone re-
placement dosages selected were not physiologic
with respect to GFR. Alternatively, because al-
dosterone secretion was not measured directly in
our study, it is conceivable that partial deficiency of
this hormone might have impaired urinary dilution
by reducing sodium reabsorption at some site in the
distal nephron. This possibility is unlikely because
the combined administration of DOCA and corti-
costerone to hypophysectomized rats failed to im-
prove urine diluting ability to a greater degree than
that achieved with corticosterone replacement
alone (group 5).
Reduction of GFR is a characteristic of both pri-
mary and secondary adrenal insufficiency and has
been considered to contribute to the defect in water
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excretion observed in both states [1, 2]. Decreased
GFR was not a primary determinant of the defect in
water excretion observed in the present study be-
cause glucocorticoid replacement restored water
excretion without increasing GFR above that ob-
served in glucocorticoid-deficient animals. Further-
more, increasing GFR to normal with extracellular
fluid volume expansion (group 6) during glucocorti-
coid deficiency resulted in only a small improve-
ment in water excretion. These results are in agree-
ment with previous reports demonstrating that vol-
ume expansion alone does not restore water
excretion in the absence of glucocorticoids [41] and
that improvement in water excretion following ste-
roid administration correlates poorly with changes
in GFR and solute excretion [3,6, 11, 17].
Another hypothesis that has been proposed to ex-
plain the defect in water excretion is that glucocorti-
coid deficiency directly increases the permeability to
water of distal nephron epithelial cells in the ab-
sence of ADH, resulting in enhanced back diffusion
of water [7, 11—13]. The evidence cited in favor of
this mechanism has been indirect. First, Kleeman et
al [7], using a bioassay, failed to detect elevated lev-
els of plasma ADH. Second, Green, Harrington,
and Valtin [15] demonstrated a defect in water ex-
cretion in adrenalectomized rats with congenital
absence of ADH (Brattleboro strain), suggesting
that ADH is not essential in the pathogenesis of the
defect. Third, binding studies have demonstrated
the presence of specific glucocorticoid receptors in
the kidney [42, 43], specifically along the cortical
portion of collecting tubules [44]. In contrast, in vi-
tro studies in the toad urinary bladder have demon-
strated that glucocorticoids increase, not decrease,
vasopressin-stimulated water transport [45]. Re-
cently, Rayson. Ray, and Morgan [46] have pro-
vided direct evidence against an increased tubular
sensitivity to vasopressin in glucocorticoid defi-
ciency. These workers have shown no differences
in basal or vasopressin-stimulated diffusional water
permeability in collecting ducts of adrenalecto-
mized and control rats using an isolated per-
fused renal papilla preparation. Thus, the available
data are conflicting and do not allow any unequivo-
cal statement concerning a direct effect of glucocor-
ticoid deficiency on water permeability in the distal
nephron. The present experimental design was not
constructed to examine this question. The results
do indicate that elevated levels of plasma AVP con-
tribute, at least in part, to the impairment in water
excretion observed in glucocorticoid deficiency.
The mechanism by which glucocorticoid defi-
ciency results in increased secretion of ADH is un-
known. Because plasma osmolality was significant-
ly decreased in glucocorticoid-deficient rats in the
present study, an osmotic stimulus to vasopressin
release can be excluded. It is unlikely that volume
depletion can account for the elevated levels of
vasopressin because chronic extracellular fluid vol-
ume expansion failed to suppress plasma AVP. This
latter finding is consistent with previous studies
demonstrating that mineralocorticoid replacement
alone in adrenal insufficiency was capable of restor-
ing both blood [17] and extracellular fluid volume
[18] to normal, despite a persistent defect in water
excretion. Therefore, it is likely that glucocorticoid
deficiency modulates ADH secretion through a non-
osmotic mechanism that is independent of plasma
or extracellular volume. Such an effect could result
from hemodynamic or humoral activation of periph-
eral afferent pathways originating in the arterial and
cardiac baroreceptors [33, 34, 47] or from a direct
effect of glucocorticoid hormones on central af-
ferent neurons that interact with neurosecretory
cells.
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